Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Social media myths about GLP-1 weight loss drugs are flooding primary care offices — and it's taking a real toll. A new survey of 374 GLP-1-prescribing providers found that 73% correct patient misinformation at least weekly, and 35% say the demand is fueling burnout. TikTok is the top culprit, with unrealistic weight loss expectations and unregulated online prescribing adding even more pressure on already stretched clinicians.
GLP-1 medications have revolutionized obesity care, but they've also unleashed a wave of misinformation that's landing squarely on primary care physicians (PCPs). A new survey by Tebra of 374 GLP-1-prescribing providers reveals that the viral spread of weight loss myths — mostly from TikTok and word of mouth — has turned misinformation correction into a near-daily clinical task. On top of that, the rise of direct-to-consumer online prescribing platforms, many of which require little more than a short questionnaire, is sending patients with unmanaged side effects and dosing confusion straight to primary care clinics.
The operational burden is significant. Providers are spending an average of 8.7 hours per week on GLP-1-related administrative duties, and the strain is pushing some toward the exit — 20% have considered reducing hours, switching specialties, or leaving practice altogether.
By the Numbers:
Why it matters: As GLP-1 demand grows — and oral formulations loom on the horizon — primary care practices face mounting pressure to manage not just the medicine, but the myth. Without systemic support, the burden risks worsening physician burnout and compromising patient safety.
